Paul Wagner is Chairman, President and Chief Executive Officer of Forte Biosciences, Inc. (FBRX). The company reported total compensation of $7,358,587 for fiscal year 2025.
| Salary | $670,051 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,951,480 |
| Non-equity incentive plan | $737,056 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $7,358,587 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Forte Biosciences, Inc. filed April 29, 2026, accession 0001193125-26-191515.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Paul Wagner this page | Chairman, President and Chief Executive Officer | $7,358,587 |
| Antony Riley | Chief Financial Officer | $2,722,440 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Forte Biosciences, Inc. compensation brief.
Paul Wagner's compensation sits inside Forte Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.